Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heribert Hänscheid

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration MeasurementsHeribert Hänscheid, Michael Lassmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Spatial dose mapping for individualizing radioiodine treatmentMichael Lassmann, Heribert Hänscheid
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 21, 2021
High-dose radiation exposure and hypothyroidism: aetiology, prevention and replacement therapyChristoph Reiners, Heribert Hänscheid, Rita Schneider
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
A perspective on post-Chernobyl radioablation in young femalesChristoph Reiners, Michael Lassmann, Heribert Hänscheid
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dosimetry prior to I-131-therapy of benign thyroid diseaseHeribert Hänscheid, Michael Lassmann, Christoph Reiners
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancerFrederik A Verburg, Heribert Hänscheid, Markus Luster
The Journal of Clinical Endocrinology and Metabolism|October 8, 2013
Approach to the patient: role of dosimetric RAI Rx in children with DTCFrederik A Verburg, Christoph Reiners, Heribert Hänscheid
Zeitschrift Fur Medizinische Physik|November 14, 2022
Determinants of target absorbed dose in radionuclide therapyHeribert Hänscheid, Michael Lassmann, Frederik A Verburg
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Impact of 131I diagnostic activities on the biokinetics of thyroid remnantsMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancerMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration MeasurementsHeribert Hänscheid, Michael Lassmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Spatial dose mapping for individualizing radioiodine treatmentMichael Lassmann, Heribert Hänscheid
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 21, 2021
High-dose radiation exposure and hypothyroidism: aetiology, prevention and replacement therapyChristoph Reiners, Heribert Hänscheid, Rita Schneider
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
A perspective on post-Chernobyl radioablation in young femalesChristoph Reiners, Michael Lassmann, Heribert Hänscheid
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dosimetry prior to I-131-therapy of benign thyroid diseaseHeribert Hänscheid, Michael Lassmann, Christoph Reiners
Best Practice & Research. Clinical Endocrinology & Metabolism|September 16, 2017
Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancerFrederik A Verburg, Heribert Hänscheid, Markus Luster
The Journal of Clinical Endocrinology and Metabolism|October 8, 2013
Approach to the patient: role of dosimetric RAI Rx in children with DTCFrederik A Verburg, Christoph Reiners, Heribert Hänscheid
Zeitschrift Fur Medizinische Physik|November 14, 2022
Determinants of target absorbed dose in radionuclide therapyHeribert Hänscheid, Michael Lassmann, Frederik A Verburg
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Impact of 131I diagnostic activities on the biokinetics of thyroid remnantsMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancerMichael Lassmann, Markus Luster, Heribert Hänscheid, et al.
Pageof 8